Two years of GDPR- what’s the verdict?
On May 25th GDPR celebrated it's two years anniversary. The European Commission announced its two-year review of the EU General…
Brexit negations started fiercely
Covered by the tsunami about news of the Corona virus, negotiations about Brexit were started this month. The British government…
New experts
Last year the Vivenics team was strengthened with two new experts, time to introduce them to you. IT project lead…
See you soon!
You can expect more newsletters from Vivenics in the near future. We also publish our blogs and posts on topics…
Lab of the Future – Methods Database on its way
As a member of the Pistoia Alliance, Vivenics has participated in the Lab of the Future Methods Database project. The…
New business
We have already mentioned our participation in the ERMD programs for MSD PharmOps and MSD Biotech, and the Dotmatics support…
Privacy and Brexit: UK last in line
EU Data Protection Supervisor Wojciech Wiewiórowski said the U.K. may have to wait before negotiations can start on a new…
Privacy and Pharma: a deal made in heaven?
During the earlier days of privacy, the pharmaceutical industry was already ahead of time in providing measures for protecting the…
People at Vivenics deliver excellent value for money
‘Smart drug development for better patient treatment and value creation’. This mission statement belongs to Swiss-based Debiopharm, a family-owned business…
Don’t worry, be weary…
I am tired. I mean really, really tired. A multitude of projects, constantly shifting between several focus areas and working…